Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Experimental group:Basic treatment of Western medicine + Shenqi Tiaoshen decoction
Control group:Basic treatment of western medicine + traditional Chinese medicine simulant
Sponsors
The First Affiliated Hospital of Anhui University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients who met the diagnostic criteria for COPD 2.It belongs to the stable phase, GOLD grade III 3.In line with the standard of TCM syndrome differentiation of lung and kidney qi deficiency syndrome 4.Age 40-80 years old 5.They did not participate in other clinical studies 3 months before enrollment 6.Antibiotics were not used 3 months before enrollment 7.Voluntary treatment, and signed informed consent
Exclusion criteria
Exclusion criteria: 1.Mild, moderate, extremely severe COPD patients and patients with acute exacerbation 2.Allergic constitution or allergies to known components of test drugs or control drugs 3.Pregnant and nursing women 4.Mentally ill, dementia, various psychiatric patients 5.Patients with cardiac function grade IV and hemodynamic instability 6.Complicated with bronchiectasis, bronchial asthma, active pulmonary tuberculosis, pulmonary embolism, pneumothorax, pleural effusion, malignant tumor and other neuromuscular diseases affecting respiratory and motor function 7.Severe liver and kidney disease ( severe liver disease refers to cirrhosis, portal hypertension and variceal bleeding, severe kidney disease including dialysis, kidney transplantation ) 8.Long-term bedridden for various reasons 9.Those who participated in other interventional clinical trials in the past 3 months 10.Researchers believe that it is not suitable to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of exacerbations and severity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dyspnea scale (MMRC);TCM clinical symptom score evaluation;Six minutes walking distance (6 MWDS);Pulmonary function;The COPD assessment test (CAT) comprehensive score;BODE index; | — |
Countries
China
Contacts
Public ContactJiabing Tong
The First Affiliated Hospital of Anhui University of Chinese Medicine
Outcome results
None listed